Silk Road Medical Inc. (SILK)

Name: Silk Road Medical Inc. (SILK) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Silk Road Medical Inc. (SILK)

Stock Card

$27.49

$0.00 (0.00%)

As on 26-Sep-2024 09:30EDT

Market cap

$1,117 Mln

Revenue (TTM)

$191 Mln

P/E Ratio

P/B Ratio

7.2

Div. Yield

0 %

Silk Road Medical (SILK) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 27.49 High: 27.49

52 Week Range

Low: -- High: --

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-0.4 %
ROCE

-- %
Industry P/E

44.46
EV/EBITDA

-12.8
Debt to Equity

0.5
Book Value

$--
EPS

$-1.4
Face value

--
Shares outstanding

40,632,100

7 Years Aggregate

CFO

$-222.16 Mln

EBITDA

$-268.64 Mln

Net Profit

$-327.59 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Silk Road Medical (SILK)	124.0	0.9	2.2	71.4	-21.0	-3.8	--
BSE Sensex^*	-9.6	-2.7	2.9	-5.0	5.4	5.7	10.4
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 26-Sep-2024 | *As on 04-Sep-2026 | #As on 26-Oct-2023

Company	2023	2022	2021	2020
Silk Road Medical (SILK)	-76.8	24.0	-32.3	56.0
S&P Small-Cap 600	13.9	-17.4	25.3	9.6
BSE Sensex	18.7	4.4	22.0	15.8

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Shareholding Pattern

View Details

About Silk Road Medical (SILK)

Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE... Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California. As of September 17, 2024, Silk Road Medical, Inc operates as a subsidiary of Boston Scientific Corporation. Read more

CFO & COO

Mr. Lucas W. Buchanan
CFO & COO

Mr. Lucas W. Buchanan
Headquarters

Sunnyvale, CA
Website

https://silkroadmed.com

FAQs for Silk Road Medical (SILK)

What is the current share price of Silk Road Medical Inc (SILK) Today?

The share price of Silk Road Medical Inc (SILK) is $27.49 (NASDAQ) as of 26-Sep-2024 09:30 EDT. Silk Road Medical Inc (SILK) has given a return of -20.97% in the last 3 years.

What is the current PB & PE ratio of Silk Road Medical Inc (SILK)?

Since, TTM earnings of Silk Road Medical Inc (SILK) is negative, P/E ratio is not available.
The P/B ratio of Silk Road Medical Inc (SILK) is 7.22 times as on 26-Sep-2024, a 91 premium to its peers’ median range of 3.79 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2023	-8.60	3.17
2022	-34.26	12.13
2021	-29.54	18.78
2020	-42.59	19.96
2019	-22.38	17.46

What is the 52 Week High and Low of Silk Road Medical Inc (SILK)?

The 52-week high and low of Silk Road Medical Inc (SILK) are Rs -- and Rs -- as of 05-Sep-2026.

What is the market cap of Silk Road Medical Inc (SILK)?

Silk Road Medical Inc (SILK) has a market capitalisation of $ 1,117 Mln as on 26-Sep-2024. As per SEBI classification, it is a Small Cap company.

Should I invest in Silk Road Medical Inc (SILK)?

Before investing in Silk Road Medical Inc (SILK), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.